针对水的新兴策略:在诊断,疫苗和治疗中应用抗原和抗体
Wei Wang1, Jia-Xiu Li2, Si-Qi Long2
1Institute for Engineering Medicine, Kunming Medical University, Kunming, 650500, China.
Military Medical Research
|October 23, 2025
概括
麻疹病毒 (MPXV) 表面抗原提供了广泛的防护对orthopoxviruses. 针对这些抗原的计算疫苗设计提供了可适应的,具有成本效益的MPXV预防和新的治疗策略.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 麻疹病毒 (MPXV) 是一种致动物性病原体,引起了严重的公共卫生问题,需要采取有效的对策.
- 包括A29L,M1R,B6R和A35R在内的MPXV表面抗原对于病毒生命周期至关重要,并在整体病毒中保存,从而使交叉保护性免疫成为可能.
研究的目的:
- 审查检测,疫苗开发和基于抗体的疗法的最新进展.
- 突出MPXV表面抗原在引起免疫反应中的作用及其治疗应用的潜力.
主要方法:
- 对MPXV研究的当前文献的审查,重点关注抗原识别和疫苗策略.
- 探索诸如反向疫苗学和免疫信息学等计算方法,以设计多表位疫苗.
- 分析MPXV抗原和抗体的诊断和治疗应用.
主要成果:
- MPXV表面抗原是开发具有针对orthopoxvirus交叉保护能力的疫苗的关键目标.
- 通过计算方法设计的多表位疫苗具有成本效益,快速验证和适应病毒突变的能力.
- MPXV抗原和抗体对早期诊断,治疗监测以及对抗药性病例的新疗法具有前景.
结论:
- 向保存的MPXV表面抗原是预防和控制水的有希望的策略.
- 计算疫苗学加速了针对MPXV的适应性和有效疫苗的开发.
- 基于抗原和抗体的方法为诊断和治疗提供了新的途径,解决了水管理的挑战.
相关概念视频
00:42Cross-reactivity
32.8K
Overview
32.8K
01:31Hybridoma Technology
17.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.2K
01:29Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936